Moderna Stock Reached New 52-Week High: What's Happening?

Moderna Inc. (NASDAQ:MRNA) shares are trading higher Friday, extending a rally that carried the stock to a fresh 52-week high near $198 on upcoming clinical trial data. Here's what you need to know.